Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Hormonal Diseases market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

23 Item(s)

Page 1 of 3

  1. Hypothyroidism - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8724IDB
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypothyroidism – Pipeline Review, H2 2016, provides an overview of the Hypothyroidism (Hormonal Disorders) pipeline landscape.
    $2,000.00

  2. Hypoparathyroidism - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Nov-2016
    , Product code: GMDHC8685IDB
    Hypoparathyroidism is decreased function of the parathyroid glands with underproduction of parathyroid hormone. This leads to low levels of calcium in the blood, often causing cramping and twitching of muscles (involuntary muscle contraction), and several other symptoms. The condition can be inherited, but it is also encountered after thyroid or parathyroid gland surgery, and it can be caused by immune system-related damage as well as a number of rarer causes. The treatment includes artificial form of the hormone that can be administered as replacement, calcium replacement or vitamin.
    $2,000.00

  3. Acromegaly - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Sep-2016
    , Product code: GMDHC8480IDB
    The report provides comprehensive information on the therapeutics under development for Acromegaly, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acromegaly and features dormant and discontinued projects.
    $2,000.00

  4. Secondary Hyperparathyroidism - Pipeline Review, H2 2016

    By: Global Markets Direct
    , Published: Jul-2016
    , Product code: GMDHC8282IDB
    The report provides comprehensive information on the therapeutics under development for Secondary Hyperparathyroidism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Secondary Hyperparathyroidism and features dormant and discontinued projects.
    $2,000.00

  5. Hypothyroidism - Pipeline Review, H1 2016

    By: Global Markets Direct
    , Published: May-2016
    , Product code: GMDHC8090IDB
    The report provides comprehensive information on the therapeutics under development for Hypothyroidism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hypothyroidism and features dormant and discontinued projects.
    $2,000.00

  6. Hypoparathyroidism - Pipeline Review, H1 2016

    By: Global Markets Direct
    , Published: May-2016
    , Product code: GMDHC8072IDB
    The report provides comprehensive information on the therapeutics under development for Hypoparathyroidism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hypoparathyroidism and features dormant and discontinued projects.
    $2,000.00

  7. Acromegaly - Pipeline Review, H1 2016

    By: Global Markets Direct
    , Published: Apr-2016
    , Product code: GMDHC7862IDB
    Global Markets Direct’s, ‘Acromegaly - Pipeline Review, H1 2016’, provides an overview of the Acromegaly pipeline landscape.
    $2,000.00

  8. Secondary Hyperparathyroidism - Pipeline Review, H1 2016

    By: Global Markets Direct
    , Published: Feb-2016
    , Product code: GMDHC7614IDB
    Global Markets Direct’s, ‘Secondary Hyperparathyroidism - Pipeline Review, H1 2016’, provides an overview of the Secondary Hyperparathyroidism pipeline landscape.
    $2,000.00

  9. Acromegaly - Pipeline Review, H2 2015

    By: Global Markets Direct
    , Published: Dec-2015
    , Product code: GMDHC7458IDB
    Global Markets Direct’s, ‘Acromegaly - Pipeline Review, H2 2015’, provides an overview of the Acromegaly’s therapeutic pipeline.
    $2,000.00

  10. Idiopathic Short Stature - Pipeline Review, H2 2015

    By: Global Markets Direct
    , Published: Aug-2015
    , Product code: GMDHC7042IDB
    Global Markets Direct’s, ‘Idiopathic Short Stature - Pipeline Review, H2 2015’, provides an overview of the Idiopathic Short Stature’s therapeutic pipeline.
    $2,000.00

23 Item(s)

Page 1 of 3